Dexcom Inc’s filing revealed that its EVP Chief Legal Officer Brown Michael Jon unloaded Company’s shares for reported $79411.0 on Apr 30 ’24. In the deal valued at $126.25 per share,629 shares were sold. As a result of this transaction, Brown Michael Jon now holds 68,212 shares worth roughly $8.84 million.
Then, Dolan Matthew Vincent sold 1,990 shares, generating $274,242 in total proceeds. Upon selling the shares at $137.81, the EVP Strategy and Corporate Dev now owns 42,377 shares.
Before that, SAYER KEVIN R sold 49,633 shares. Dexcom Inc shares valued at $6,864,136 were divested by the President CEO and Chairman at a price of $138.30 per share. As a result of the transaction, SAYER KEVIN R now holds 283,893 shares, worth roughly $36.81 million.
RBC Capital Mkts initiated its Dexcom Inc [DXCM] rating to an Outperform in a research note published on March 12, 2024; the price target was $165. Raymond James also remained covering DXCM and has increased its forecast on April 17, 2023 with a “Strong buy” recommendation from previously “an Outperform” rating. UBS started covering the stock on March 29, 2023. It rated DXCM as “a Buy”.
Price Performance Review of DXCM
On Monday, Dexcom Inc [NASDAQ:DXCM] saw its stock jump 1.00% to $129.65. Over the last five days, the stock has gained 3.05%. Dexcom Inc shares have risen nearly 4.48% since the year began. Nevertheless, the stocks have risen 10.42% over the past one year. While a 52-week high of $142.00 was reached on 03/26/24, a 52-week low of $74.75 was recorded on 02/28/24. SMA at 50 days reached $131.93, while 200 days put it at $114.85. A total of 1.86 million shares were traded, compared to the trading of 2.31 million shares in the previous session.
Levels Of Support And Resistance For DXCM Stock
The 24-hour chart illustrates a support level at 128.31, which if violated will result in even more drops to 126.98. On the upside, there is a resistance level at 130.46. A further resistance level may holdings at 131.28. The Relative Strength Index (RSI) on the 14-day chart is 46.63, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -2.37, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 59.33%. Stochastics %K at 31.85% indicates the stock is a holding.
The most recent change occurred on January 26, 2023 when Wolfe Research began covering the stock and recommended ‘”an Outperform”‘ rating along with a $121 price target.
